NABL Accredited · Containment Monitoring · Regulatory Support

Potent Compound Containment Monitoring Program

A dedicated monitoring programme for highly potent API containment, environmental controls, and surface contamination in pharmaceutical manufacturing and packaging operations.

Auriga Research delivers a potent compound containment monitoring programme for pharmaceutical facilities handling highly potent active pharmaceutical ingredients (HPAPIs). Our programme monitors air, surfaces and personnel pathways to verify containment effectiveness, prevent cross-contamination, and support regulatory inspections.

Containment monitoring is critical in environments where microgram-level exposures can affect product quality and worker safety. Our methodology includes real-time air sampling, filter analysis, surface swabs, and targeted cleaning verification — all in line with current GMP, WHO, US FDA, and CDSCO expectations.

What the programme covers

  • Air monitoring for containment zones, transfer systems, and exhaust points
  • Surface wipe testing on equipment, benches, personnel doors, and gowning areas
  • Personnel monitoring for glove and garment contamination during handling
  • Cleaning validation checks and post-cleaning residual surveys
  • Containment audit support for isolators, RABS, negative-pressure suites, and barrier systems

Why this matters for pharmaceutical manufacturers

Highly potent compounds require disciplined containment and monitoring because even trace contamination can cause cross-contamination, batch rejection, or regulatory findings. A structured containment monitoring programme gives manufacturers the data needed to demonstrate control and compliance during audits and dossier submissions.

How Auriga supports your containment controls

Our laboratory provides the analytical capability to test exposure control systems and support hazardous compound handling. We integrate environmental monitoring with risk-based sampling, validated analytical methods, and expert interpretation so that each monitoring cycle produces actionable information for process improvement.

Once you fill out the form, you will:
  • Receive a call or email from our team to understand your containment requirement
  • Get a customised monitoring plan based on your facility and process
  • Receive a quotation that matches the scope of your potent compound programme
  • Submit samples and receive regulatory-grade analytical reports

Who should use this programme

  • HPAPI manufacturers operating potent compound suites
  • Contract manufacturers handling batch-to-batch potent products
  • Facilities that require periodic containment audits and environmental validation
  • Quality teams preparing for CDSCO, US FDA, or WHO inspections
  • Companies with multicompound facilities needing contamination control assurance

Frequently Asked Questions

What is a potent compound containment monitoring program?
A potent compound containment monitoring program tracks airborne and surface contamination in manufacturing, filling, and packaging areas where highly potent APIs are handled. It combines environmental monitoring, personnel monitoring, and cleaning verification to protect people, product quality, and regulatory compliance.
Which regulations does this program support?
Our program supports GMP compliance, CDSCO requirements, and international guidelines such as WHO, EU GMP Annex 1, and US FDA expectations for containment and hazard control in potent compound facilities.
What samples are collected during monitoring?
We collect air samples, surface swabs, filter extracts, and wipe tests from critical containment zones. Monitoring also covers personnel garments and gloves, spill areas, waste handling, and transfer points to confirm that containment barriers are effective.
Can Auriga Research support highly potent API (HPAPI) manufacturing?
Yes. Auriga Research provides containment monitoring support for HPAPI manufacturing, including monitoring of isolators, RABS, barriers, and containment enclosures. Our laboratory helps verify that facility controls meet the required occupational exposure limits and cleanroom classification targets.
How does the program improve safety and quality?
Regular containment monitoring identifies leaks, cross-contamination risks, and cleaning gaps before they become batch failures or regulatory findings. It demonstrates to auditors that the facility operates under disciplined containment control and that environmental hazards are managed proactively.

Need a Potent Compound Containment Monitoring Programme?

Get a customised monitoring plan for air, surface and personnel contamination control in HPAPI facilities.

+91-7428116100 Request a Quote
Call Now Get a Quote

Type to search services, tests, and locations…